Subcutaneous tri-block copolymer produces recovery from spinal cord injury.
We have studied the ability of nonionic detergents and hydrophilic polymers to seal permeabilized membranes of damaged cells, rescuing them from progressive dissolution, degeneration, and death. We report that a single subcutaneous injection of the tri-block copolymer, Poloxamer 188 (P188) 6 hr after a severe compression of the adult guinea pig spinal cord is able to: (1). preserve the anatomic integrity of the cord; (2). produce a rapid recovery of nerve impulse conduction through the lesion; and (3). produce a behavioral recovery of a spinal cord dependent long tract spinal cord reflex. These observations stood out against a control group in blinded evaluation. Conduction through the lesion was monitored by stimulating the tibial nerve of the hind limb, and measuring the arrival of evoked potentials at the contralateral sensory cortex of the brain (somatosensory evoked potentials; SSEP). Behavioral recovery was determined by a return of sensitivity of formerly areflexic receptive fields of the cutaneous trunchi muscle (CTM) reflex. This contraction of back skin in response to tactile stimulation is totally dependent on the integrity of an identified bilateral column of ascending long tract axons. A statistically significant recovery of both SSEP conduction through the lesion and the CTM reflex occurred in P188-treated animals compared to vehicle-treated controls. Quantitative 3D computer reconstruction of the lesioned vertebral segment of spinal cord revealed a statistically significant sparing of spinal cord parenchyma and a significant reduction in cavitation of the spinal cord compared to control animals We determined that the proportion of P188-treated animals that recovered evoked potentials were nearly identical to that produced by a subcutaneous injection of polyethylene glycol (PEG). In contrast, P188 was not as effective as PEG in producing a recovery of CTM functioning. We discuss the likely differences in the mechanisms of action of these two polymers, and the possibilities inherent in a combined treatment.
Borgens
Richard B
RB
Center for Paralysis Research, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, USA. cpr@purdue.edu
Bohnert
Debbie
D
Duerstock
Brad
B
Spomar
Daniel
D
Lee
Raphael C
RC
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D004594:Electrophysiology; D005073:Evoked Potentials, Somatosensory / Q000502:physiology; D016166:Free Radical Scavengers / Q000008:administration & dosage / Q000627:therapeutic use; D006168:Guinea Pigs; D006470:Hemorrhage / Q000188:drug therapy / Q000473:pathology; D007091:Image Processing, Computer-Assisted; D007279:Injections, Subcutaneous; D018482:Muscle, Skeletal / Q000473:pathology; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D020442:Poloxamer / Q000008:administration & dosage / Q000627:therapeutic use*; D013117:Spinal Cord Compression / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
D016166:Free Radical Scavengers; D020442:Poloxamer